Articles

         1998-2001 | 2002-2003 | 2004 | 2005 | 2006 | 2007 | 2008 | 2009 | 2010 | 2011

2011

Menzies N, Salomon JA. Non-monotonicity in the episodic random utility model. Health Economics 2011 20(12):1523-1531..

Studdert DM, Kachalia AB, Salomon JA, Mello MM. Rationalizing noneconomic damages: a health-utilities approach. Law and Contemporary Problems 2011; 74(3):57-101.

Pande A, Ross-Degnan D, Zaslavsky A, Salomon JA. Effects of healthcare reforms on coverage, access and disparities: quasi-experimental analysis of evidence from Massachusetts. American Journal of Preventive Medicine 2011; 41(1):1-8.

Bärnighausen T, Kyle M, Salomon JA, Waning B. Assessing the population health impact of market interventions to improve access to antiretroviral treatment. Health Policy and Planning 2011; (in press).

Salomon JA, Patel A, Neal B, Glasziou P, Grobbee DE, Chalmers J, Clarke PM. Comparability of patient-reported health status: multi-country analysis of EQ-5D responses in patients with type 2 diabetes. Medical Care 2011; 2011; 49(10):962-970.

[BACK TO TOP]

 

2010

Rudan I, Chan KY, Zhang JS, Theodoratou E, Feng XL, Salomon JA, Lawn JE, Cousens S, Black RE, Guo Y, Campbell H; WHO/UNICEF’s Child Health Epidemiology Reference Group (CHERG). Causes of deaths in children younger than 5 years in China in 2008. Lancet 2010; 375(9720):1083-9.

Lee GM, Salomon JA, Gay C, Hammitt JK. Preferences for health outcomes associated with Group A Streptococcal disease and vaccination. Health Qual Life Outcomes 2010; 8:28. [PDF 268KB]

Clarke PM, Glasziou P, Patel A, Chalmers J, Woodward M, Harrap SB, Salomon JA; ADVANCE Collaborative Group. Event rates, hospital utilization, and costs associated with major complications of diabetes: a multicountry comparative analysis. PLoS Med 2010; 7(2):e1000236. [PDF 268KB]

Kim SY, Goldie SJ, Salomon JA. Exploring model uncertainty in economic evaluation of health interventions: the example of rotavirus vaccination in Vietnam. Medical Decision Making 2010; 30(5):E1-E28 .

Brown T, Bao L, Raftery AE, Salomon JA, Baggaley RF, Stover J. Modelling country-level HIV/AIDS epidemics in the antiretroviral therapy era: the UNAIDS Estimation and Projection Package 2009. Sexually Transmitted Infections 2010; 86(S2):ii3-ii10.

Hogan DR, Zaslavsky A, Hammitt JK, Salomon JA. Flexible epidemiologic model for estimation and short-term projections in generalized HIV/AIDS epidemics. Sexually Transmitted Infections 2010; 86(S2):ii84-ii92.

Goldhaber-Fiebert JD, Lipsitch M, Mahal A, Zaslavsky AM, Salomon JA. Quantifying child mortality reductions related to measles vaccination. PLoS ONE 2010; 5(11): e13842.

Profit J, Lee D, Zupancic JA, Papile L, Gutierrez C, Goldie SJ, Gonzalez-Pier E, Salomon JA. Clinical benefits, costs and cost-effectiveness of neonatal intensive care in Mexico. PLoS Medicine 2010; 7(12):e1000379.

[BACK TO TOP]

 

2009

Craig B, Busschbach JV, Salomon JA. Keep it simple: Ranking health states yields values similar to cardinal measurement approaches. Journal of Clinical Epidemiology 2009; 62(3):296-305. [PDF 220KB]

Kim SY, Goldie SJ, Salomon JA. Cost-effectiveness of Rotavirus vaccination in Vietnam. BMC Public Health 2009; 9(1):29. [PDF 331KB]

Craig B, Busschbach JV, Salomon JA. Ranking, time trade-off and visual analogue scale values for EQ-5D health states. Medical Care 2009; 47(6): 634-41.

Ikeda N, Murray CJL, Salomon JA. Tracking population health based on self-reported impairments: trends in the prevalence of hearing loss in US adults, 1978-2006. American Journal of Epidemiology 2009; 170(1):80-87. [PDF 196KB]

Salomon JA, Nordhagen S, Oza S, Murray CJL. Are Americans feeling less healthy? The puzzle of trends in self-rated health in the United States. American Journal of Epidemiology 2009; 170(3):343-51. [PDF 384KB] [Comment] [Reply]

[BACK TO TOP]

 

2008

Goldhaber-Fiebert JD, Stout NK, Salomon JA, Kuntz KM, Goldie SJ. Cost-effectiveness analysis of HPV DNA testing and prophylactic HPV vaccination in the United States. JNCI 2008; 100(5):308-20. [PDF 476KB]

Sánchez MS, Lloyd-Smith JO, Porco TC, Williams BG, Borgdorff MW, Mansoer J, Salomon JA, Getz WM. Impact of HIV on novel therapies for tuberculosis control. AIDS 2008; 22(8):963-72. [PDF 520KB]

Brown T, Salomon JA, Alkema L, Raftery A, Gouws E. Progress and challenges in modeling country-level HIV/AIDS epidemics: the UNAIDS Estimation and Projection Package 2007. Sexually Transmitted Infections 2008; 84 Suppl 1:i5-i10. [PDF 1.7MB]

Salomon JA, Hogan DR. Evaluating the impact of antiretroviral therapy on HIV transmission. AIDS 2008; 22 Suppl 1:S149-59. [PDF 271KB]

Andersson KL, Salomon JA, Chung RT, Goldie SJ. Cost effectiveness of alternative surveillance strategies for hepatocellular carcinoma in patients with cirrhosis. Clin Gastroenterol Hepatol 2008; 6(12):1418-24. [PDF 353KB] [Supplementary Materials]

[BACK TO TOP]

 

2007

Campos NG, Salomon JA, Servoss JC, Nunes DP, Samet JH, Freedberg KA, Goldie SJ. Cost-effectiveness of treatment for hepatitis C in an urban cohort co-infected with HIV. Am J Med 2007; 120(3): 272-9. [PDF 330KB]

Bhalla K, Ezzati M, Mahal A, Salomon J, Reich M. A risk-based method for modeling traffic fatalities. Risk Analysis 2007; 27(1): 125-36. [PDF 1.2MB]

Krabbe PFM, Salomon JA, Murray CJL. Quantification of health states with rank-based nonmetric multidimensional scaling. Medical Decision Making 2007; 27(4):395-405. [PDF 512KB]

Goldie SJ, Kim JJ, Kobus K, Goldhaber-Fiebert JD, Salomon J, O’Shea MKH, Bosch FX, de Sanjosé S, Franco EL. Cost-effectiveness of HPV 16, 18 vaccination in Brazil. Vaccine 2007; 25(33):6257-70. [PDF 1.2MB]

Kim SY, Salomon JA, Goldie SJ. Economic evaluation of hepatitis B vaccination in low income countries: an application of cost-effectiveness affordability curves. Bulletin of the World Health Organization 2007; 85(11):833-42. [PDF 244KB] [Technical Appendix]

Goldhaber-Fiebert JD, Stout NK, Ortendahl J, Kuntz KM, Goldie SJ, Salomon JA. Modeling  human papillomavirus and cervical cancer in the United States for analysis of screening and vaccination. Population Health Metrics 2007; 5(11). [PDF 514KB]

Nunn A, Fonseca EM, Bastos FI, Gruskin S, Salomon JA. Evolution of antiretroviral drug costs in Brazil in the context of free and universal access to AIDS treatment. PLoS Medicine 2007; 4(11):e305 [PDF 636 KB]

[BACK TO TOP]

 

2006

Salomon JA, Lloyd-Smith JO, Getz WM, Resch S, Sánchez MS, Porco TC, Borgdorff MW. Prospects for advancing tuberculosis control efforts through novel therapies. PLoS Med 2006; 3(8): e273. [PDF 762KB] [Web Appendix]

González-Pier E, Gutiérrez-Delgado C, Stevens G, Barraza-Lloréns M, Porras-Condey R, Carvalho N, Loncich K, Dias R, Kulkarni S, Casey A, Murakami Y, Ezzati M, Salomon JA. Priority-setting for health interventions in Mexico’s System of Social Protection in Health. Lancet 2006; 268(9547):1608-18. [PDF 131KB]

-Reprinted in Spanish in Salúd Publica de México 2007; 49(Suppl1):S27-S52. [PDF 122KB]  

Pongou R, Ezzati M, Salomon JA. Household and community socioeconomic and environmental determinants of child nutritional status in Cameroon. BMC Public Health 2006; 6(1):98. [PDF 388KB]

Pongou R, Salomon JA, Ezzati M. Health impacts of macroeconomic crises and policies: determinants of variation in childhood malnutrition trends in Cameroon. International Journal of Epidemiology 2006; 35(3):648-56. [PDF 120KB]

Resch S, Salomon JA, Murray M, Weinstein MC. Cost-effectiveness of treatment for multidrug resistant tuberculosis. PLoS Medicine 2006; 3(7):e241. [PDF 182KB] [Web Appendix] [Additional Tables and Figures]

Michaud CM, McKenna MT, Begg S, Tomijima N, Majmudar M, Bulzacchelli MT, Ebrahim S,Ezzati M, Salomon JA, Kreiser JG, Hogan M, Murray CJL. The burden of disease and injury in the United States, 1996. Population Health Metrics 2006; 4:11. [PDF 563KB]

Kim JJ, Salomon JA, Weinstein MC, Goldie SJ. Packaging health care services in a single cervical cancer screening visit for older women in resource-poor settings. PLoS Medicine 2006; 3(11): e434. [PDF 189 KB] [Web Appendix]

[BACK TO TOP]

 

2005

Salomon JA, Hogan DR, Stover J, Stanecki K, Walker N, Ghys PD, Schwartländer B. Integrating HIV prevention and treatment: from slogans to impact. PLoS Med 2005; 2(1): e16. [PDF 938KB] [Web Appendix] [Web Figure]

Hogan DR, Salomon JA. Prevention and treatment of human immunodeficiency virus / acquired immunodeficiency syndrome in resource-limited settings. Bulletin of the World Health Organization 2005; 83(2):135-143. [PDF 315KB]

Hogan DR, Baltussen R, Hayashi C, Lauer J, Salomon JA. Cost effectiveness analysis of strategies to combat HIV/AIDS in developing countries. BMJ 2005; 331(7530):1431-7. [PDF 298KB] [Web Appendix]

Marston M, Zaba B, Salomon JA, Brahmbhatt H, Bagenda D. Estimating the net effect of HIV on child mortality in African populations affected by generalised HIV epidemics. JAIDS: Journal of Acquired Immune Deficiency Syndromes 2005; 38(2):219-227. [PDF 340KB]

Lee GM, Salomon JA, LeBaron CW, Lieu TA. Health-state valuations for pertussis: methods for valuing short-term health states. Health and Quality of Life Outcomes 2005; 3:17. [PDF 324KB]

Lee GM, Salomon JA, Friedman J, Hibberd P, Ross-Degnan D, Zasloff E, Bediako S, Goldmann D. Reduced transmission of daycare-associated illness in the home:  A possible role for alcohol-based hand gels. Pediatrics 2005; 115(4):852-60. [PDF 129KB]

Evans DB, Adam T, Tan-Torres Edejer T, Lim SS, Cassels A, Evans TG, the WHO-CHOICE Millennium Development Goals Team [Baltussen R, Chisholm D, Johns B, Lauer J, Salomon JA]. Time to reassess strategies for improving health in developing countries. BMJ 2005; 331(7525):1133-1136. [PDF 115KB]

Evans DB, Tan-Torres Edejer T, Adam T, Lim SS, WHO-CHOICE Millennium Development Goals Team [Baltussen R, Chisholm D, Johns B, Lauer J, Salomon JA]. Methods to assess the costs and health effects of interventions for improving health in developing countries. BMJ 2005; 331(7525):1137-1140. [PDF 115KB]

Evans DB, Lim SS, Adam T, Tan-Torres Edejer T, WHO-CHOICE Millennium Development Goals Team [Baltussen R, Chisholm D, Johns B, Lauer J, Salomon JA]. Evaluation of current strategies and future priorities for improving health in developing countries. BMJ 2005; 331(7530):1457-61. [PDF 87KB]

[BACK TO TOP]

 

2004

Salomon JA, Weinstein MC, Goldie SJ. Taking account of future technology in cost-effectiveness analysis. BMJ 2004; 329(7468): 733-736. [PDF 393KB]

Salomon JA, Murray CJL. A multi-method approach to measuring health-state valuations. Health Economics 2004; 13(3): 281-90. [PDF 149KB]

Salomon JA, Tandon A, Murray CJL. Comparability of self rated health: cross-sectional multi-country survey study using anchoring vignettes. BMJ 2004; 328(7434): 258-61. [PDF (Abridged) 104KB] [PDF (Full) 117KB]

King G, Murray CJL, Salomon JA, Tandon A. Enhancing the validity and cross-population comparability of measurement in survey research. American Political Science Review 2004; 98(1): 567-583. [PDF 478KB]

Mathers CD, Iburg KM, Salomon JA, Tandon A, Chatterji S, Ustün B, Murray CJL. Global patterns of healthy life expectancy in the year 2002. BMC Public Health 2004; 4:66. [PDF 341KB]

[BACK TO TOP]

 

2002-2003

Salomon JA. Reconsidering the use of rankings in the valuation of health states: a model for estimating cardinal values from ordinal data. Population Health Metrics 2003; 1:12. [PDF 331KB]

Salomon JA, Weinstein MC, Hammitt JK, Goldie SJ. Cost-effectiveness of treatment for chronic hepatitis C infection in an evolving patient population. JAMA 2003; 290(2): 228-237. [PDF 138KB]

Murray CJL, Ferguson BD, Lopez AD, Guillot M, Salomon JA, Ahmad O. Modified logit life table system: principles, empirical validation, and application. Population Studies 2003; 57(2):165-182[PDF 290KB]

Mathers CD, Murray CJL, Salomon JA, Sadana R, Tandon A, Lopez AD, Ustün B, Chatterji S. Healthy life expectancy: comparison of OECD countries in 2001. Australian and New Zealand Journal of Public Health 2003; 27(1):5-11[PDF 56KB]

Salomon JA, Weinstein MC, Hammitt JK, Goldie SJ. Empirically-calibrated model of hepatitis C virus infection in the United States. American Journal of Epidemiology 2002; 156(8): 761-773. [PDF 347KB]

Stover J, Walker N, Garnett GP, Salomon JA, Stanecki KA, Ghys PD, Grassly NC, Anderson RM, Schwartländer B. Can we reverse the HIV/AIDS pandemic with an expanded response? Lancet 2002; 360: 73-77. [PDF 82KB] Web Appendices: [1] [2] [3]

Salomon JA, Murray CJL. The epidemiologic transition re-examined: compositional models for causes of death by age and sex. Population and Development Review 2002; 28(2): 205-228. [PDF 2.6MB]

Mathers CD, Murray CJL, Lopez AD, Sadana R, Salomon JA. Global patterns of healthy life expectancy for older women. Journal of Women and Aging 2002; 14(1/2):99-118. [PDF 154KB]

[BACK TO TOP]

 

1998-2001

Salomon JA, Murray CJL. Modelling HIV/AIDS epidemics in sub-Saharan Africa using seroprevalence data from antenatal clinics. Bulletin of the World Health Organization 2001; 79(7) 596-607. [PDF 387KB]

Mathers CD, Sadana R, Salomon JA, Murray CJL, Lopez AD. Healthy life expectancy in 191 countries, 1999. Lancet 2001; 357: 1685-91. [PDF 198KB]

Murray CJL, Salomon JA, Mathers CD. A critical examination of summary measures of population health.Bulletin of the World Health Organization 2000; 78(8):981-94. [PDF 788KB]

Murray CJL, Salomon JA. Modeling the impact of global tuberculosis control strategies. Proceedings of the National Academy of Sciences USA 1998; 95(23): 13881-6. [PDF 321KB][Technical Supplement]

Murray CJL, Salomon JA. Expanding the WHO tuberculosis control strategy: rethinking the role of active case-finding. International Journal of Tuberculosis and Lung Disease 1998; 2(9 Suppl. 1):S9-15. [PDF 129KB]

[BACK TO TOP]